Speaker illustration

Doctor Sara Tommasi

Flinders Medical Centre and Flinders University, Adelaide (Australia)

Dimethylarginine dimethylaminohydrolase-1 (DDAH-1) inhibition by proton pump inhibitors: in vitro and in vivo significance

Event: ESC Congress 2016

Topic: Metabolism and metabolic syndromes

Session: Metabolism and hypertrophy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb